Fund Holdings — Birchview Capital, LP

Total Portfolio Value:
$115.49M
Total Bought:
$8.18M
Total Sold:
$20.60M
Net Transaction:
-$12.42M
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Bristol-Myers Squibb Company(BMY)688,218686,182-2,036$28.58M$35.50M30.74%+$6.92M
Biodesix, Inc.(BDSX)5,696,1135,696,1130$8.70M$10.12M8.76%+$1.42M
Acadia Pharmaceuticals Inc250,400400,400+150,000$4.07M$6.16M5.33%+$2.09M
Elutia Inc.(ELUT)1,551,6551,321,215-230,440$7.70M$5.03M4.36%-$2.66M
United Therapeutics Corporation(UTHR)10,00010,0000$3.19M$3.58M3.10%+$398.0K
Prothena Corp PlcSHS
SHS
203,574209,574+6,000$4.20M$3.51M3.04%-$695.6K
Neurocrine Biosciences, Inc.(NBIX)42,24030,240-12,000$5.82M$3.48M3.02%-$2.33M
Corcept Therapeutics Incorporated(CORT)74,00074,0000$2.40M$3.42M2.97%+$1.02M
Harrow, Inc.(HROW)150,00072,910-77,090$3.13M$3.28M2.84%+$144.5K
Quidelortho Corp67,61967,6190$2.25M$3.08M2.67%+$837.1K
Foghorn Therapeutics Inc.(FHTX)320,930320,9300$1.85M$2.99M2.59%+$1.14M
Axogen, Inc.(AXGN)197,000197,0000$1.43M$2.76M2.39%+$1.34M
Phreesia, Inc.(PHR)114,700114,7000$2.43M$2.61M2.26%+$182.4K
Stoke Therapeutics, Inc.(STOK)210,000210,0000$2.84M$2.58M2.23%-$256.2K
Protagonist Therapeutics Inc48,00048,0000$1.66M$2.16M1.87%+$496.8K
Travere Therapeutics, Inc.(TVTX)122,000148,000+26,000$1.00M$2.07M1.79%+$1.07M
Masimo Corp15,28015,2800$1.92M$2.04M1.76%+$112.9K
Ovintiv Inc.(OVV)74,20052,200-22,000$3.48M$2.00M1.73%-$1.48M
DocGo Inc.(DCGO)460,000515,000+55,000$1.42M$1.71M1.48%+$288.4K
Castle Biosciences, Inc.(CSTL)34,00058,000+24,000$740.2K$1.65M1.43%+$914.0K
Alkermes plcSHS(ALKS)50,00050,0000$1.21M$1.40M1.21%+$194.5K
EQT Corporation(EQT)034,619+34,619$0$1.27M1.10%+$1.27M
Alphatec Holdings, Inc.(ATEC)88,000198,000+110,000$919.6K$1.10M0.95%+$181.3K
Kalvista Pharmaceuticals Inc46,00082,000+36,000$541.9K$949.6K0.82%+$407.7K
Kiniksa Pharmaceuticals Ltd30,00030,0000$560.1K$749.7K0.65%+$189.6K
10x Genomics, Inc.CL A(TXG)30,00030,0000$583.5K$677.4K0.59%+$93.9K
Halozyme Therapeutics, Inc.(HALO)10,00010,0000$523.6K$572.4K0.50%+$48.8K
Accelerate Diagnostics Inc325,239325,2390$380.5K$556.2K0.48%+$175.6K
Cytokinetics, Incorporated(CYTK)10,00010,0000$541.8K$528.0K0.46%-$13.8K
Inhibrx Biosciences, Inc.(INBX)12,11032,110+20,000$170.6K$502.8K0.44%+$332.3K
Keros Therapeutics, Inc.(KROS)7,0007,0000$319.9K$406.5K0.35%+$86.6K
Apellis Pharmaceuticals Inc
COM
14,00014,0000$537.0K$403.8K0.35%-$133.3K
Treace Medical Concepts, Inc.(TMCI)068,350+68,350$0$396.4K0.34%+$396.4K
Xenon Pharmaceuticals Inc.(XENE)10,00010,0000$389.9K$393.7K0.34%+$3.8K
Karyopharm Therapeutics Inc.(KPTI)469,832469,8320$407.6K$390.0K0.34%-$17.7K
Coherus Oncology, Inc.(CHRS)270,000372,000+102,000$467.1K$386.9K0.33%-$80.2K
Arvinas, Inc.(ARVN)15,00015,0000$399.3K$369.4K0.32%-$29.9K
Progyny Inc22,00022,0000$629.4K$368.7K0.32%-$260.7K
Biohaven Pharmaceutical Holding Co Ltd7,3657,3650$255.6K$368.0K0.32%+$112.4K
Axsome Therapeutics, Inc.(AXSM)4,0004,0000$322.0K$359.5K0.31%+$37.5K
Cullinan Therapeutics, Inc.(CGEM)20,00020,0000$348.8K$334.8K0.29%-$14.0K
Wave Life Sciences, Inc.SHS(WVE)40,00040,0000$199.6K$328.0K0.28%+$128.4K
Springworks Therapeutics Inc10,00010,0000$376.7K$320.4K0.28%-$56.3K
NovoCure Limited(NVCR)20,00020,0000$342.6K$312.6K0.27%-$30.0K
Sarepta Therapeutics, Inc.(SRPT)2,5002,5000$395.0K$312.2K0.27%-$82.8K
BioCryst Pharmaceuticals, Inc.(BCRX)40,00040,0000$247.2K$304.0K0.26%+$56.8K
Amicus Therapeutics Inc
COM
28,00028,0000$277.8K$299.0K0.26%+$21.3K
Blueprint Medicines Corp02,700+2,700$0$249.8K0.22%+$249.8K
Xencor, Inc.(XNCR)12,30012,3000$232.8K$247.4K0.21%+$14.5K
Gossamer Bio, Inc.(GOSS)138,176138,1760$124.5K$136.3K0.12%+$11.8K
Bluebird Bio Inc311,200211,200-100,000$306.3K$109.7K0.10%-$196.6K
Alumis Inc010,000+10,000$0$106.8K0.09%+$106.8K
Liquidia Corporation(LQDA)10,00010,0000$120.0K$100.0K0.09%-$20.0K
uniQure N.V.SHS(QURE)020,000+20,000$0$98.6K0.09%+$98.6K
InflaRx N.V.(IFRX)50,00050,0000$87.0K$76.5K0.07%-$10.5K
2seventy Bio Inc17,83315,833-2,000$68.7K$74.7K0.06%+$6.1K
Ventyx Biosciences Inc28,80028,8000$66.5K$62.8K0.05%-$3.7K
Zentalis Pharmaceuticals, Inc.(ZNTL)16,00016,0000$65.4K$58.9K0.05%-$6.6K
Cabaletta Bio, Inc.(CABA)10,00010,0000$74.8K$47.2K0.04%-$27.6K
Outset Medical, Inc.(OM)10,00010,0000$38.5K$6.8K0.01%-$31.7K
CERo Therapeutics Holdings, Inc.CL A(CERO)12,97212,9720$3.9K$1.2K0.00%-$2.7K
Equitrans Midstream Corporatio133,0500-133,050$1.73M$0—-$1.73M
Exxon Mobil Corp5,8490-5,849$673.3K$0—-$673.3K
G1 Therapeutics Inc80,0000-80,000$182.4K$0—-$182.4K
Silk Road Medical Inc158,0940-158,094$4.27M$0—-$4.27M
Page 1 of 1
Birchview Capital, LP — 13F Holdings — Q3 2024 | TickerTrail